BeStock  
Stocks › CNS

Cohen & Steers CNS

US equityMarket cap rank #2317Asset Management
$73.02 +$0.02 (+0.03%)
Pre-market · Oct 6, 7:40 am ET · After hours $73.02 0.00%
Open$74.19
Prev close$73.00
Day range$71.61 – $74.19
Volume287.4K
Market cap$3.75B
P/E (TTM)22.5
Dividend yield3.53%

CNS Stock News

Headlines matching Cohen & Steers or the CNS ticker, most recent first.

  • CNS: We have launched "U-Way Recovery Solutions," a service that supports business continuity and rapid recovery in OCI environments.JPX · 16 Sep 2026
  • LG CNS to Acquire KRW381.4 Billion in NVIDIA GPU Equipment for AI FactoryMT Newswires · 11 Sep 2026
  • LG CNS Targets U.S. Ad Market With Agentic AI-Powered Marketing SolutionPR Newswire · 31 Aug 2026
  • Evercore Maintains Cohen & Steers(CNS.US) With Buy Rating, Raises Target Price to $88Market news · 10 Aug 2026
  • Evercore Maintains Cohen & Steers(CNS.US) With Buy Rating, Raises Target Price to $84Market news · 10 Jul 2026
  • Evercore Maintains Cohen & Steers(CNS.US) With Buy Rating, Raises Target Price to $82Market news · 8 Jun 2026
  • CNS: An IR interview article has been published (IR Agents).JPX · 5 Jun 2026
  • CNS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Charles Faith L.SEC · 20 May 2026
  • Maxim Group Maintains CNS Pharmaceuticals(CNSP.US) With Buy Rating, Maintains Target Price $10Market news · 15 May 2026
  • BofA Securities Maintains Cohen & Steers(CNS.US) With Sell Rating, Maintains Target Price $53Market news · 6 Apr 2026
  • Evercore Maintains Cohen & Steers(CNS.US) With Buy Rating, Cuts Target Price to $76Market news · 20 Apr 2026
  • Evercore Initiates Cohen & Steers(CNS.US) With Buy Rating, Announces Target Price $75Market news · 10 Apr 2026
  • Maxim Group Maintains CNS Pharmaceuticals(CNSP.US) With Buy Rating, Cuts Target Price to $10Market news · 6 Mar 2026
  • INSILICO: VOLUNTARY ANNOUNCEMENTINSILICO MEDICINE AND TENACIA BIOTECHNOLOGY EXPANDAI-DRIVEN CNS COLLABORATION WITH ADDITIONAL DEAL VALUEUP TO USD94.75 MILLIONHKEX · 26 Mar 2026
  • LG CNS Co: Report on Significant Holdings of Stocks, Etc. (Short Form)OPENDART · 2 Oct 2026

Discussion

No comments yet — be the first to weigh in on CNS.

Leave a comment

Scroll to Top